Oxyntomodulin
A gut hormone that acts on GLP-1 and glucagon-related pathways and helped shape the modern obesity-peptide conversation.
Also referenced as: OXM
Also appears in: Hormone
This compound has a genuine development or study trail, but it is not an approved routine drug.
Primary lane: Weight Loss. Also surfaces under Hormone for browsing and discovery.
OXM
No FDA label signal · 54 trials · 490 PubMed results
What oxyntomodulin is
Oxyntomodulin is an endogenous gut hormone with relevance to both GLP-1 and glucagon-related metabolic signaling.
Why it matters
It is one of the foundational physiology peptides behind many modern obesity-drug ideas, even when it is not the final commercial molecule people hear about.
Regulatory context
Oxyntomodulin is not FDA approved as a mainstream therapeutic peptide in the United States.
Practical reading note
Some peptides matter because they are marketed widely. Others matter because later blockbuster drugs were built on the physiology they helped define. Oxyntomodulin is in the second category.